Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
PC secure video path
Stacked thin-film superlattice thermoelectric devices
Flexible organic light emitting device and manufacturing method thereof
Opioid-nornicotine codrugs combinations for pain management
Manufacturing method power semiconductor device
Puncture resistant fabric
Machine tool with an electrical generator for passive power generation
  Randomly Featured Patents
Method and apparatus for heating subsurface soil for decontamination
Arc tube for discharge lamp device
Ion pump having protective mask components overlying the cathode elements
Automated design process and method for multi-rail cells and connections
Electronic module assembly for filtered feedthroughs
Hook for hanging plastic vent pipes
Fire fighting nozzle and method including pressure regulation, chemical and eduction features
Liquid crystal display panel
Heating and cooking apparatus
Motor vehicle oil dipstick means